CytoVale last raised $16.4M in its Debt (Dec 2020).
- ·The complete investor list: 35 names
- ·Watch CytoVale: the Monday email on marks, rounds and moves
CytoVale funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2020 | Debt | $16.4M | ▮ | ▮ |
| Oct 2019 | Early Stage VC | $7.4M | ▮ | ▮ |
| Dec 2017 | Early Stage VC | $7.2M | ▮ | ▮ |
Membership and data by Private Market View
CytoVale valuation
CytoVale's last known valuation is $340 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has CytoVale raised?
CytoVale has raised $228 million in total; 3 of its rounds are on record, from 2017 on. The largest on record was a $7.4 million early-stage round in Oct 2019; the most recent was a $16.4 million debt round in Dec 2020.
CytoVale has filed 4 Form Ds with the SEC since 2017, most recently in Jan 2022 ($16.4 million sold to 23 investors).
How CytoVale's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CytoVale, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about CytoVale
- What is CytoVale worth?
- CytoVale's last known valuation is $340.0M.
- How much has CytoVale raised?
- CytoVale has raised $228.2M in total funding across 3 recorded rounds.
- When did CytoVale last raise?
- CytoVale last raised in Dec 2020 (Debt), raising $16.4M.